Indaptus Therapeutics, Inc. filed a Current Report on Form 8-K to report the appointment of Robert Martell, M.D., Ph.D. as a member of the Company's board of directors and the appointment of Walt A. Linscott as the Company's Chief Operating Officer. The Board also set the date of the Company's 2023 annual meeting of stockholders.